Occidental Petroleum’s Strategic Shift Meets Market Skepticism

Investors in Occidental Petroleum experienced a dramatic reversal of fortune on Thursday, as initial optimism over a major corporate transaction gave way to significant share price declines. The market’s negative response appeared paradoxical given Warren Buffett’s Berkshire Hathaway agreement to acquire OxyChem, the chemical subsidiary, for $9.7 billion—a deal that would seemingly strengthen the energy company’s financial position.

Financial Restructuring and Market Concerns

The transaction represents a pivotal moment in Occidental’s ongoing strategic transformation. Company leadership plans to allocate $6.5 billion from the sale proceeds toward debt reduction, aiming to bring total liabilities below $15 billion. This move would sharpen the corporation’s focus on its core oil and gas extraction operations in the Permian Basin, alongside its developing low-carbon technology initiatives.

Despite these apparent benefits, market participants expressed reservations that triggered the stock’s downward trajectory after early gains. Financial analysts raised questions about both the timing and valuation of the arrangement. Many observers considered the sale price insufficient, particularly given OxyChem’s recent financial performance—the division generated nearly $5 billion in revenue over the past twelve months and stood at the threshold of substantially increased cash flow generation.

Leadership Changes and Strategic Context

Concurrent with the landmark transaction, Occidental announced significant executive changes. Richard A. Jackson assumes the role of Chief Operating Officer, taking responsibility for global oil and gas operations in addition to low-carbon technology development. Jackson previously guided Oxy Low Carbon Ventures to commercial viability and has been instrumental in advancing technologies including Direct Air Capture and lithium extraction.

Should investors sell immediately? Or is it worth buying Occidental Petroleum?

For Chief Executive Officer Vicki Hollub, the divestiture of OxyChem represents the “final step” in a strategic overhaul that commenced nearly ten years ago. The company’s debt burden had expanded considerably following two major acquisitions: the $38.7 billion purchase of Anadarko Petroleum in 2019 and the $12 billion CrownRock acquisition completed in August 2024.

Future Implications and Investor Uncertainty

The true test for Occidental Petroleum lies ahead. The transaction is scheduled for finalization in the fourth quarter of 2025, pending regulatory approvals. Financial markets will closely monitor whether the promised debt reduction delivers the anticipated financial stability.

For Warren Buffett, the arrangement consolidates his already substantial stake in Occidental—Berkshire Hathaway currently maintains approximately 27% ownership in the company. Shareholders, however, face lingering questions: Does selling the profitable chemical division represent strategic brilliance that will strengthen the company’s long-term position, or a costly misstep that will ultimately diminish corporate value?